Immunoassay - Global Market Outlook (2015-2022)

Immunoassay - Global Market Outlook (2015-2022)

  • Published: May 2016
  • ID: SMRC15685

According to Stratistics MRC, the global immunoassay market is estimated at $16.35 billion in 2015 and is expected to grow at a CAGR of 10.9% to reach $33.72 billion by 2022. Technological advancements and increasing geriatric population worldwide are some of the key factors fuelling the market growth. Increasing incidences of infectious & chronic diseases, demand for non-invasive diagnostic techniques, broad usage of immunoassays in oncology, growing need of reagents and speed, cost effectiveness & accuracy of immunoassay are additional drivers playing a key role in the growth of immunoassay market. However, execution of excise duty by the U.S. government and low detection limit are the factors limiting the market growth. Expansion of pharmaceutical and biotechnology industries in emerging regions such as Asia Pacific acts as opportunity for immunoassay market.

In 2015, Enzyme-Linked Immunosorbent Assay (ELISA) and Enzyme-linked ImmunoSpot (ELISPOT) assay dominated the global immunoassay technology market due to their high sensitivity and long term presence in the market. Oncology segment is witnessing a significant growth driven by the high incidence of cancer diseases. North America is anticipated to be the largest market for immunoassay, whereas Asia Pacific and MEA are projected to grow at a faster pace. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population. 

The technological advancements, rising investments in pharmaceutical and biotechnology sector by government and corporate sector and rapidly growing healthcare market in emerging countries such as China and India are the factors favouring the market growth in this region.

Some of the key players in the global immunoassay market include Roche Diagnostics Limited, Thermo Fisher Scientific, Inc, Danaher Corporation, Siemens Healthcare, Becton, Dickinson And Company, Abbott Laboratories, Inc, Luminex Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Biomérieux SA, Ortho-Clinical Diagnostics, Inc., Alere, Inc., Qiagen NV, Meridian Life Science, Inc and Syntron Bioresearch, Inc.

Products & Services Covered:
• Software and Services
• Analyzers
o Purchase Modes Analysers
o Analyser Type
• Reagents & KITS
o Radioimmunoassay (RIA)
o Western Blot
o Polymerase Chain Reaction (PCR)
o Enzyme-Linked Immunospot (ELISPOT)
o Rapid Tests
o Enzyme-Linked Immunosorbent Assay (ELISA) Reagents

Technologies Covered:
• Radio Immunoassays (RIA)
• Nephelometric Immunoassay
• Western Blot
• Fluorescence Immunoassay
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Tests
• Polymerase Chain Reaction (PCR)
• Chemiluminescence Immunoassay
• Enzyme-linked ImmunoSpot (ELISPOT) Assay

End Users Covered:
• Pharma & Biotech Firms
• Blood Banks
• Hospitals
• Clinical Laboratories
• Academic Research Centers
• Contract Research Organizations
• Other End Users

Applications Covered:
• Cardiology
• Autoimmune Disorders
• Oncology
• Toxicology
• Infectious Diseases
• Neonatal Screening
• Hematology and Blood Screening
• Endocrinology
• Bone and Mineral Disorders
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancement

1 Executive Summary    
      
2 Preface
     
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Product Analysis   
 3.7 Technology Analysis  
 3.8 End User Analysis   
 3.9 Application Analysis  
 3.10 Emerging Markets   
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Immunoassay Market, By Product & Service 
 5.1 Introduction   
 5.2 Software and Services  
 5.3 Analyzers   
  5.3.1 Purchase Modes Analysers 
   5.3.1.1 Outright Purchase 
   5.3.1.2 Reagent Rental Purchase
  5.3.2 Analyser Type  
   5.3.2.1 Open NDED Systems
   5.3.2.2 Closed NDED Systems
 5.4 Reagents & KITS   
  5.4.1 Radioimmunoassay (RIA) 
  5.4.2 Western Blot  
  5.4.3 Polymerase Chain Reaction (PCR)
  5.4.4 Enzyme-Linked Immunospot (ELISPOT)
  5.4.5 Rapid Tests  
  5.4.6 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents
      
6 Global Immunoassay Market, By Technology 
 6.1 Introduction   
 6.2 Radio Immunoassays (RIA)  
 6.3 Nephelometric Immunoassay  
 6.4 Western Blot   
 6.5 Fluorescence Immunoassay  
 6.6 Enzyme-Linked Immunosorbent Assay (ELISA)
 6.7 Rapid Tests   
 6.8 Polymerase Chain Reaction (PCR) 
 6.9 Chemiluminescence Immunoassay 
 6.10 Enzyme-linked ImmunoSpot (ELISPOT) Assay
      
7 Global Immunoassay Market, By End User  
 7.1 Introduction   
 7.2 Pharma & Biotech Firms  
 7.3 Blood Banks   
 7.4 Hospitals    
 7.5 Clinical Laboratories  
 7.6 Academic Research Centers  
 7.7 Contract Research Organizations 
 7.8 Other End Users   
      
8 Global Immunoassay Market, By Application 
 8.1 Introduction   
 8.2 Cardiology   
 8.3 Autoimmune Disorders  
 8.4 Oncology    
 8.5 Toxicology   
 8.6 Infectious Diseases   
 8.7 Neonatal Screening   
 8.8 Hematology and Blood Screening  
 8.9 Endocrinology   
 8.10 Bone and Mineral Disorders  
 8.11 Other Applications   
      
9 Global Immunoassay Market, By Geography 
 9.1 North America   
  9.1.1 US   
  9.1.2 Canada   
  9.1.3 Mexico   
 9.2 Europe    
  9.2.1 Germany   
  9.2.2 France   
  9.2.3 Italy   
  9.2.4 UK   
  9.2.5 Spain   
  9.2.6 Rest of Europe  
 9.3 Asia Pacific   
  9.3.1 Japan   
  9.3.2 China   
  9.3.3 India   
  9.3.4 Australia   
  9.3.5 New Zealand  
  9.3.6 Rest of Asia Pacific  
 9.4 Rest of the World   
  9.4.1 Middle East  
  9.4.2 Brazil   
  9.4.3 Argentina  
  9.4.4 South Africa  
  9.4.5 Egypt   
      
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers  
 10.3 New Product Launch  
 10.4 Expansions   
 10.5 Other Key Strategies  
      
11 Company Profiling    
 11.1 Roche Diagnostics Limited  
 11.2 Thermo Fisher Scientific, Inc  
 11.3 Danaher Corporation  
 11.4 Siemens Healthcare   
 11.5 Becton, Dickinson And Company 
 11.6 Abbott Laboratories, Inc  
 11.7 Luminex Corporation  
 11.8 Bio-Rad Laboratories, Inc.  
 11.9 Sysmex Corporation  
 11.10 Biomérieux SA    
 11.11 Ortho-Clinical Diagnostics, Inc. 
 11.12 Alere, Inc.   
 11.13 Qiagen NV   
 11.14 Meridian Life Science, Inc  
 11.15 Syntron Bioresearch, Inc.  


List of Tables     
1 Global Immunoassay Market Outlook, By Region (2013-2022) ($MN)
2 Global Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
3 Global Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
4 Global Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
5 Global Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
6 Global Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
7 Global Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
8 Global Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
9 Global Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
10 Global Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
11 Global Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
12 Global Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
13 Global Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
14 Global Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
15 Global Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
16 Global Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
17 Global Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
18 Global Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
19 Global Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
20 Global Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
21 Global Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
22 Global Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
23 Global Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
24 Global Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
25 Global Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
26 Global Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
27 Global Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
28 Global Immunoassay Market Outlook, By End User (2013-2022) ($MN)
29 Global Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
30 Global Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
31 Global Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
32 Global Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
33 Global Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
34 Global Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
35 Global Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
36 Global Immunoassay Market Outlook, By Application (2013-2022) ($MN)
37 Global Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
38 Global Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
39 Global Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
40 Global Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
41 Global Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
42 Global Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
43 Global Immunoassay Market Outlook, By Hematology and Blood Screening  (2013-2022) ($MN)
44 Global Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
45 Global Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
46 Global Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
47 North America Immunoassay Market Outlook, By Country (2013-2022) ($MN)
48 North America Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
49 North America Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
50 North America Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
51 North America Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
52 North America Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
53 North America Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
54 North America Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
55 North America Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
56 North America Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
57 North America Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
58 North America Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
59 North America Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
60 North America Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
61 North America Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
62 North America Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
63 North America Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
64 North America Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
65 North America Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
66 North America Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
67 North America Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
68 North America Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
69 North America Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
70 North America Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
71 North America Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
72 North America Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
73 North America Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
74 North America Immunoassay Market Outlook, By End User (2013-2022) ($MN)
75 North America Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
76 North America Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
77 North America Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
78 North America Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
79 North America Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
80 North America Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
81 North America Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
82 North America Immunoassay Market Outlook, By Application (2013-2022) ($MN)
83 North America Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
84 North America Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
85 North America Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
86 North America Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
87 North America Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
88 North America Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
89 North America Immunoassay Market Outlook, By Hematology and Blood Screening  (2013-2022) ($MN)
90 North America Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
91 North America Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
92 North America Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
93 Europe Immunoassay Market Outlook, By Country (2013-2022) ($MN)
94 Europe Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
95 Europe Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
96 Europe Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
97 Europe Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
98 Europe Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
99 Europe Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
100 Europe Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
101 Europe Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
102 Europe Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
103 Europe Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
104 Europe Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
105 Europe Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
106 Europe Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
107 Europe Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
108 Europe Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
109 Europe Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
110 Europe Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
111 Europe Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
112 Europe Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
113 Europe Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
114 Europe Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
115 Europe Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
116 Europe Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
117 Europe Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
118 Europe Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
119 Europe Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
120 Europe Immunoassay Market Outlook, By End User (2013-2022) ($MN)
121 Europe Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
122 Europe Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
123 Europe Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
124 Europe Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
125 Europe Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
126 Europe Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
127 Europe Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
128 Europe Immunoassay Market Outlook, By Application (2013-2022) ($MN)
129 Europe Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
130 Europe Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
131 Europe Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
132 Europe Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
133 Europe Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
134 Europe Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
135 Europe Immunoassay Market Outlook, By Hematology and Blood Screening  (2013-2022) ($MN)
136 Europe Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
137 Europe Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
138 Europe Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
139 Asia Pacific Immunoassay Market Outlook, By Country (2013-2022) ($MN)
140 Asia Pacific Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
141 Asia Pacific Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
142 Asia Pacific Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
143 Asia Pacific Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
144 Asia Pacific Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
145 Asia Pacific Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
146 Asia Pacific Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
147 Asia Pacific Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
148 Asia Pacific Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
149 Asia Pacific Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
150 Asia Pacific Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
151 Asia Pacific Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
152 Asia Pacific Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
153 Asia Pacific Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
154 Asia Pacific Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
155 Asia Pacific Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
156 Asia Pacific Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
157 Asia Pacific Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
158 Asia Pacific Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
159 Asia Pacific Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
160 Asia Pacific Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
161 Asia Pacific Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
162 Asia Pacific Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
163 Asia Pacific Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
164 Asia Pacific Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
165 Asia Pacific Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
166 Asia Pacific Immunoassay Market Outlook, By End User (2013-2022) ($MN)
167 Asia Pacific Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
168 Asia Pacific Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
169 Asia Pacific Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
170 Asia Pacific Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
171 Asia Pacific Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
172 Asia Pacific Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
173 Asia Pacific Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
174 Asia Pacific Immunoassay Market Outlook, By Application (2013-2022) ($MN)
175 Asia Pacific Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
176 Asia Pacific Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
177 Asia Pacific Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
178 Asia Pacific Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
179 Asia Pacific Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
180 Asia Pacific Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
181 Asia Pacific Immunoassay Market Outlook, By Hematology and Blood Screening  (2013-2022) ($MN)
182 Asia Pacific Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
183 Asia Pacific Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
184 Asia Pacific Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
185 RoW Immunoassay Market Outlook, By Country (2013-2022) ($MN)
186 RoW Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
187 RoW Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
188 RoW Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
189 RoW Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
190 RoW Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
191 RoW Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
192 RoW Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
193 RoW Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
194 RoW Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
195 RoW Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
196 RoW Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
197 RoW Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
198 RoW Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
199 RoW Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
200 RoW Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
201 RoW Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
202 RoW Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
203 RoW Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
204 RoW Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
205 RoW Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
206 RoW Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
207 RoW Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
208 RoW Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
209 RoW Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
210 RoW Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
211 RoW Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
212 RoW Immunoassay Market Outlook, By End User (2013-2022) ($MN)
213 RoW Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
214 RoW Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
215 RoW Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
216 RoW Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
217 RoW Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
218 RoW Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
219 RoW Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
220 RoW Immunoassay Market Outlook, By Application (2013-2022) ($MN)
221 RoW Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
222 RoW Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
223 RoW Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
224 RoW Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
225 RoW Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
226 RoW Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
227 RoW Immunoassay Market Outlook, By Hematology and Blood Screening  (2013-2022) ($MN)
228 RoW Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
229 RoW Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
230 RoW Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials